Rheums for Improvement:
Building Bridges in Evidenced-Based SLE Care


Kichul Ko, MD

Associate Professor of Medicine
Section of Rheumatology
University of Chicago
Chicago, IL

Anisha Dua, MD, MPH

Associate Professor of Medicine
Northwestern University Feinberg School of Medicine
Chicago, IL

Program Overview

The healthcare landscape reveals a stark disparity in the availability of specialized rheumatology care for systemic lupus erythematosus (SLE) for patients residing in rural regions. This void has resulted in suboptimal treatment strategies, with patients often lacking access to the latest evidence-based interventions and, consequently, experiencing deteriorated health outcomes. Telementoring emerges as a promising solution to this challenge, offering an avenue for rural HCPs to access expert guidance from seasoned specialists in urban centers. This series will address crucial educational gaps, from reducing the over-reliance on glucocorticoids to optimizing the use of newer biologic agents, thereby fostering improved patient care. Furthermore, with an emphasis on enhancing patient adherence and addressing health disparities, the telementoring initiative will elevate the standard of care, ensuring rural SLE patients receive comprehensive, equitable, and quality treatment comparable to their urban counterparts.

Target Audience

The intended primary audience for this activity is US-based rheumatology healthcare professionals (MDs, PAs and NPs) who care for patients with SLE.

Learning Objectives

Upon completion of this activity, the participant should be able to:

  • Identify methodologies to promote equitable and patient-centered care for diverse SLE populations in rural settings keeping in mind barriers such as: patient education, communication, and cultural differences.
  • Apply evidence-based strategies to reduce glucocorticoid dependence while maintaining disease control in SLE patients.
  • Develop personalized treatment plans that optimize the use of newer biologic agents in eligible patients, taking into consideration individual patient needs.


Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Iridium Continuing Education (Iridium). Global is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation

Global Education Group designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Instructions to Receive Credit

In order to receive credit for this activity, the participant must
  • Read the learning objectives and faculty disclosures Complete the pretest
  • View the broadcast
  • Complete the posttest with a score of 70% or higher

A statement of credit will be issued within four weeks of receipt of a completed activity evaluation form.

Fee Information and Refund/Cancellation Policy

There is no fee for this educational activity.

Contact Information

For information about the accreditation of this program, please contact Global at 303-395-1782 or


Disclosures of Relevant Financial Relationships

​Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.

All relevant financial relationships have been mitigated.

The faculty have the following relevant financial relationships with ineligible companies:

Kichul Ko, MD
Consulting Fee (eg, Advisory Board):​ GlaxoSmithKline, Aurinia Pharmaceuticals​
Contracted Research (Principal Investigators must provide information, even if received by the institution): Amgen

Kimberly Trotter, MD
Contracted Research (Principal Investigators must provide information, even if received by the institution): Aurinia Pharmaceuticals​

Amber Young, MD
Nothing to disclose. ​

Gurwant Kaur, MD
Nothing to disclose. ​​

Anisha Dua, MD, MPH
Consultant, Advisor, or Speaker: AbbVie, Chemocentryx, Novartis, Sanofi

The following planners and managers involved in the development of this activity have no relevant financial relationships with ineligible companies to disclose.

The planners and managers at Global Education Group have no relevant financial relationships to disclose.

Iridium staff and others involved with the planning, development, and review of the content for this activity have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global and Iridium do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
This activity is jointly provided by Global Education Group and Iridium Continuing Education.


This educational activity is supported by an independent educational grant from AstraZeneca.

Activity Credit Amount: 1.00
Maximum Credit Amount: 3.00
Credit Type: AMA
Release: July 27, 2024
Expiration: July 27, 2025